Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
Blood test may guide smarter lung cancer therapy
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab improves survival in people with advanced non-small cell lung cancer. About 63 adults with stage IV or stage IIIB/C lung cancer that has not been trea…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Lung cancer clues hidden in old records: study seeks better predictors of survival
Knowledge-focused Recruiting nowThis study reviews medical records from 150 people with stage IIIA lung cancer who had chemotherapy before surgery. Researchers want to see if the amount of tumor killed by treatment can predict how long patients live and whether the cancer comes back. No new treatments are given…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC